Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,316.49
(
0.16%
)
News Focus
News Focus
Post# of 80490
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: rurik post# 14249

Wednesday, 11/16/2011 3:13:03 PM

Wednesday, November 16, 2011 3:13:03 PM

Post# of 80490
I'm being conservative here - we haven't seen the long-term safety data yet, and CML treatment tends to be fairly sticky. Yes, pona has the potential to be a >$1b drug in several years, but that is quite a while off yet. Meantime, what we know right now is that the drug will be approved and used for 3rd line.

Peter

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today